Oatmeal meal test to study stomach movement in eosinophilic gastritis
Part of Blood & lymphatic, Digestive system, Immune system & allergy clinical trials.
This study looks at how your stomach moves (gastric motility) in people with eosinophilic gastritis, using a special oatmeal meal. The goal is to better understand stomach function and how it may relate to symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A prior endoscopy showed eosinophilic gastritis (at least 30 eosinophils per area of biopsy, with symptoms).
- Your symptoms started at least 1 year before screening and include things like nausea, vomiting, belly pain/bloating, early fullness, regurgitation, or diarrhea.
- In the last 60 days, you’ve had stomach-type symptoms such as nausea, vomiting, early satiety, or feeling full/bloated after eating.
- You can safely eat the oatmeal meal used in the study.
- You do not have the excluded conditions listed by the study (like other eosinophilic gut diseases or certain immune or stomach surgery histories).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study studies how a standardized meal affects digestion using special monitoring in children and young adults with stomach or gut symptom problems (and compares them to healthy controls). It may help doctors understand what causes gut symptoms and guide better treatments.
This study looks at how eosinophilic inflammation in the esophagus and intestines affects outcomes like symptoms and test findings. It may help clinicians better understand these conditions and track what changes over time.
This study looks at whether abnormal function of the pyloric “stomach outlet” muscle is linked to gastroparesis symptoms (slow stomach emptying). It may help researchers better understand what causes symptoms and guide future treatments.
This study looks at how useful the POEM procedure is for people with gut “motility” (trouble moving food through the digestive tract). If you’re already scheduled for POEM, your team will also track how well it helps and whether it’s practical in real care.
This study tests a stomach mapping device (BSGM) to see how a prokinetic medication changes stomach activity in people with gastroparesis or functional dyspepsia. If you qualify, you'll have two non-invasive recordings—one before and one during your treatment.
This study looks at how diabetes affects stomach function by measuring stomach activity with special tests. It may help doctors better understand and treat stomach problems in people with diabetes.
Hear when a new Gastroparesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.